GSK has reached ... 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has agreed to pay $2.2 billion to settle ...

The three-day hearing comes a few months after GSK decided to settle a complaint brought ... The common claim in the lawsuits is that a contaminant in Zantac (ranitidine) called N ...

GlaxoSmithKline's two major American operating points are in University City, Pa., and Durham, N.C. The lawsuit says GSK lied to investors about Zantac ... Yost said GSK agreed to pay up to ...